A single arm, open, prospective, multicenter clinical study of albumin binding paclitaxel combined with apatinib mesylate in the treatment of relapsed / refractory small cell lung cancer
Latest Information Update: 04 Aug 2020
At a glance
- Drugs Paclitaxel (Primary) ; Rivoceranib (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 04 Aug 2020 New trial record